Details of the Drug Reposition

General Information of This Drug (ID: DME7K0P)

Drug Name
Oportuzumab monatox   DME7K0P

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Bladder cancer DISUHNM0 2C94 Phase 3 [1]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Head and neck cancer DISBPSQZ 2D42 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)